Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment.
about
Antiviral T-cell therapyToxicity and management in CAR T-cell therapyEngineered T cells for cancer treatmentActivation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanomaOptimizing the production of suspension cells using the G-Rex "M" series.Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.Cytoprotective effects of high dose of α-galactosylceramide against activation-induced CD4+ T and CD8+ T cell death as an adjuvant.New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancerDendritic cells: an immunotherapy coming of ageBioreactors get personal.The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity.Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.Chimeric antigen receptor-redirected T cells return to the benchSurrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.Global Manufacturing of CAR T Cell Therapy.Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.Towards a commercial process for the manufacture of genetically modified T cells for therapy.Immunogenicity of somatic mutations in human gastrointestinal cancers.CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia.Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1.A Review of Immune Therapy in Cancer and a Question: Can Thermal Therapy Increase Tumor Response?Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011".Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting.Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules.Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges.Immunotherapies: Exploiting the Immune System for Cancer Treatment.Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer
P2860
Q27028006-2576FB28-BC25-4CD2-874A-97A55DA61355Q28075314-E841DA10-59E8-4E02-A1E5-2B61C5A71AFFQ33578792-CDB4658E-C5F6-4C05-9ED7-052D5F81A95BQ34350259-7EA86EB4-E2AD-4F01-A397-172A894C5E76Q35184232-A6F3E99C-9571-4BB9-AC66-550FA8A7AB55Q35507358-2718DA15-14DB-4ACD-B74A-108A58E3F069Q35563824-8B555D35-F6D2-43E4-9ADD-B49F9CEA3BC2Q35854042-288C0368-5A2C-4D0C-9232-C766E6DC2B0EQ35996395-009CCFBE-0771-458C-9D30-E4C29F040DC7Q36411093-F756FDCC-CABF-4FF8-B17A-93B7CF1FA06EQ36456512-0AC34E5D-0D48-488B-8CD5-6D5045716FA4Q36710982-25DC5901-9459-4CA5-B225-DDC44718252BQ37065838-24CA26A3-DC26-45BB-80B8-708C2D43B3F1Q37301510-8D7996F1-5B5D-425A-869E-92E632507383Q37706835-D5481785-01E5-488E-8258-67341399897AQ37717884-D9BDE674-45D7-4868-B046-03D808A681B7Q38217028-2F7F38BC-2518-41F8-B03B-49517F56FF5FQ38329158-4854443B-33BC-4344-B32F-E09CC73130DFQ38823554-1CA4FBF1-B984-4160-8891-CC44015E53F5Q39032901-DB5119DA-967C-4CF7-98AC-DFA627F14D62Q41338135-A799312D-4D5E-426E-B3B7-7A1C043340F6Q41928232-B1D568C5-5152-47AF-9806-C4FBE7914BE6Q43215055-AF1334B2-4B85-4DE4-B890-95EB2E56C81BQ46507832-228C4C53-9857-4404-8FB9-0B6C7A4548FEQ48168880-26BC4582-DE6E-4F17-BB95-BDCCAABBA106Q54940615-466C57F7-1800-43E8-9CE8-1D228684C246Q55362851-1C318FC2-EB3B-4A68-BE60-1F50E3899971Q57152489-E4C1FB5E-1FA0-43B1-B036-85433CE671A1
P2860
Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Simplified method of the growt ...... needed for patient treatment.
@ast
Simplified method of the growt ...... needed for patient treatment.
@en
type
label
Simplified method of the growt ...... needed for patient treatment.
@ast
Simplified method of the growt ...... needed for patient treatment.
@en
prefLabel
Simplified method of the growt ...... needed for patient treatment.
@ast
Simplified method of the growt ...... needed for patient treatment.
@en
P2093
P2860
P1476
Simplified method of the growt ...... needed for patient treatment.
@en
P2093
David F Stroncek
Jianjian Jin
John R Wilson
Marianna Sabatino
Mark E Dudley
Robert Somerville
Steven A Rosenberg
P2860
P304
P356
10.1097/CJI.0B013E31824E801F
P577
2012-04-01T00:00:00Z